About

David DeSalvo is the Vice-President of Combination Product Development at Kindeva Drug Delivery. He is an expert in drug delivery devices (combination products) and has invented, designed, developed and launched multiple devices. His work has resulted in dozens of highly successful unique drug-device combination products, including many industry-first innovations.

Mr DeSalvo’s previous roles include Senior Director of Device Development at Emergent BioSolutions, Chief Executive Officer at Nuance Designs, Senior Director at SHL Medical and New Product Development Lead at BD.

Mr DeSalvo holds a Bachelor’s and Master’s degree in Mechanical Engineering from Rensselaer Polytechnic Institute (NY, US) and an MBA from Marist College (NY, US).

Contributions

EXPERT VIEW

IDENTIFYING AND OVERCOMING THE CHALLENGES OF INJECTABLE COMBINATION PRODUCT EVOLUTION

David DeSalvo considers some potential challenges that the rapid evolution of autoinjectors (and combination product injectables in general) raises, along with how the industry can successfully address this cycle of reinvention.